greeksoup/ stock research

Establishment Labs Holdings (ESTA) Q4 FY2024 earnings: revenue $45 million, up 41.0% on the year

Establishment Labs Holdings Inc. (ESTA) reported revenue of $45 million for Q4 FY2024, the quarter ended 31 December 2024, up 41.0% on the same quarter a year earlier. Net income was -$35 million, and diluted earnings per share $-1.19. The figures are the company's own, from the 10-K it filed with the SEC on 28 February 2025.

Revenue$45 millionup 41.0%
Net income-$35 million
Diluted EPS$-1.19
QuarterQ4 FY2024ended 31 December 2024

The quarter, against the one before and a year earlier

LineQ4 FY2024Q3 FY2024Q4 FY2023Change on the year
Revenue44.540.231.6+41.0%
Cost of revenue14.014.511.0+27.8%
Gross profit30.525.720.6+48.1%
Gross margin68.5%63.9%65.2%
Research and development5.14.85.8-11.6%
Selling, general and administrative44.034.136.9+19.4%
Operating income-18.7-13.1-22.1n/a
Operating margin-41.9%-32.7%-70.1%
Interest expense5.95.34.3+37.1%
Pre-tax income-35.9-16.2-23.0n/a
Income tax-1.40.5-2.5n/a
Net income-34.5-16.7-20.5n/a
Net margin-77.6%-41.5%-65.1%
Diluted EPS-$1.19-$0.59-$0.79n/a
$ million except per share.
Read moreFourth quarters are the year less the first three quarters. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow and capital returned

LineQ4 FY2024Q3 FY2024Q4 FY2023Change on the year
Operating cash flow-20.7-12.5-8.1n/a
Capital expenditure0.51.50.7-18.9%
Free cash flow-21.3-13.9-8.8n/a
Free cash flow margin-47.8%-34.6%-27.9%
Cash from investing-1.8-2.8-4.6n/a
Cash from financing74.5-0.00.1+114501.5%
Depreciation and amortisation1.61.30.9+77.8%
Share-based compensation3.53.73.5+2.8%
Diluted shares, weighted29m28m26m+11.1%
Shares outstanding at period end29m28m26m+10.4%

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet at quarter end

LineQ4 FY2024Q3 FY2024Q4 FY2023Change on the year
Shareholders' equity53.132.718.4+188.6%
Short-term borrowings0.0n/an/an/a
Debt220194189+16.3%
Operating lease liabilities4.23.82.7+55.0%
Other liabilities70.051.858.8+19.0%
Total liabilities and equity347283269+29.1%
Fixed assets78.079.477.2+1.1%
Goodwill1.20.50.5+160.0%
Intangible assets11.79.88.0+46.3%
Cash and equivalents90.339.740.0+125.7%
Receivables65.067.346.9+38.5%
Inventory78.867.179.5-0.9%
Other assets21.818.916.6+31.6%
Total assets347283269+29.1%

Questions

What was Establishment Labs Holdings' revenue in Q4 FY2024?

Establishment Labs Holdings (ESTA) reported revenue of $45 million for Q4 FY2024, the quarter ended 31 December 2024, up 41.0% on the same quarter a year earlier.

How much did Establishment Labs Holdings earn in Q4 FY2024?

Net loss for Q4 FY2024 was $35 million, and the diluted loss per share $1.19.

When did Establishment Labs Holdings report Q4 FY2024 results?

Establishment Labs Holdings filed its 10-K for the year that ended with the quarter on 28 February 2025; the fourth quarter is the year less the first three.

Quarterly results, the last 20 quarters

Q3 FY2021Q4 FY2021 *Q1 FY2022Q2 FY2022Q3 FY2022Q4 FY2022 *Q1 FY2023Q2 FY2023Q3 FY2023Q4 FY2023 *Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024 *Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026
Revenue29.035.338.541.238.243.846.548.638.531.637.244.140.244.541.451.353.864.659.967.5
Cost of revenue9.411.113.513.712.215.616.418.312.511.012.815.214.514.013.616.016.119.117.519.8
Gross profit19.624.224.927.526.028.230.130.326.120.624.428.925.730.527.835.337.745.542.347.7
Gross margin68%69%65%67%68%64%65%62%68%65%66%66%64%68%67%69%70%70%71%71%
R&D3.96.03.64.95.36.56.56.97.15.84.35.54.85.15.15.24.65.45.25.1
SG&A24.827.626.933.031.334.831.737.040.036.928.932.834.144.039.744.237.244.043.646.9
Operating income-9.0-9.4-5.6-10.4-10.5-13.2-8.2-13.7-21.0-22.1-8.8-9.3-13.1-18.7-16.9-14.1-4.0-3.9-6.5-4.3
Operating margin-31%-27%-14%-25%-27%-30%-18%-28%-55%-70%-24%-21%-33%-42%-41%-27%-7%-6%-11%-6%
Interest expense2.32.32.33.43.92.23.83.63.74.34.45.25.35.95.96.06.27.27.17.0
Pre-tax income-14.6-13.4-5.5-36.5-18.0-12.7-11.1-15.8-28.6-23.0-15.8-16.8-16.2-35.9-19.8-15.6-10.7-11.9-13.1-11.7
Net income-14.7-14.2-5.9-37.1-18.6-13.6-11.9-16.7-29.3-20.5-16.2-17.2-16.7-34.5-20.7-16.6-11.1-2.6-13.4-11.7
Net margin-51%-40%-15%-90%-49%-31%-26%-34%-76%-65%-44%-39%-41%-78%-50%-32%-21%-4%-22%-17%
Diluted EPS-$0.61-$0.60-$0.24-$1.52-$0.76-$0.55-$0.48-$0.65-$1.12-$0.79-$0.58-$0.62-$0.59-$1.19-$0.70-$0.57-$0.38-$0.09-$0.45-$0.39
Operating cash flow-12.5-7.7-4.8-11.3-22.0-14.0-20.6-28.2-31.5-8.1-11.2-14.2-12.5-20.7-20.7-18.8-11.2-0.2-4.3-16.6
Capital expenditure1.0n/a0.80.60.51.00.43.13.70.73.30.81.50.50.81.61.81.81.93.7
Free cash flow-13.4n/a-5.6-11.9-22.5-15.0-21.0-31.4-35.2-8.8-14.5-15.0-13.9-21.3-21.5-20.4-13.1-2.0-6.2-20.3
Shares outstanding24m24m24m24m24m24m24m26m26m26m27m28m28m29m29m29m29m29m29m30m
Filing10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

10-K for the period ended 31 December 2024, filed 28 February 2025: the filing.